Skip to content
Parakho

Dr Lalchandani Labs Ltd

BSE 541299

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with BSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ crore—vs a year ago6M FY26
Revenue from operations——2.13
Other income——-0.00
Total income——2.13
Employee benefit expense——0.40
Finance costs——0.01
Depreciation & amortisation——0.29
Total expenses——2.62
Profit before tax——-0.16
Tax expense——-0.03
Profit after tax——-0.13
Total comprehensive income———
Earnings per share
Earnings per share, basic—₹-0.15
Earnings per share, diluted—₹-0.15

6M FY26 — from the company’s filing with BSE. Source

Why the dash

Parakho has not ingested this company’s year-ago quarter, so the change column stays empty. A dash means we do not hold the figure — never that it is zero.

Earnings call

Dr Lalchandani Labs Ltd has not filed a concall transcript in the last 4 quarters.

Filings

12 shown · 14 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Healthcare › Healthcare Service Provider

Classification as published by BSE.

Companies also in Healthcare Service Provider, in alphabetical order

All 32 companies in Healthcare Service Provider

Page generated from filings held to 30 Sept 2026.